ARCHIVES

Funding and Direction of IL-2/LAK Trials Questioned By DCT Board

This article is from The Cancer Letter archive.

Vol. 15 No. 09 | March 3, 1989

Download PDF Visit The Full Archive

Related Articles

NCI Asks Centers To Limit Increases In Applying For Support Grant Renewals.

October 12, 2001

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003

NCI-Approved Clinical Trials

July 30, 2004

Quality of Care: ASCO Publishes “Top Five” Ways to Improve Cancer Care

November 1, 2013

Workshop concludes HPV Vaccines Would Be Valuable, Feasible

April 8, 1988

Research Funding: 30 Groups Sign Letter For Double NCI Budget

January 23, 1998